To assess whether Caspase activation was also involved in the observed reduction in cell viability, we measured the activity of effector caspases and demonstrated that HRK significantly increased caspase 3/7 activity in all GBM cell lines tested (Fig. 1e), however to different degrees. This evidence concerns the gene HRK and glioblastoma.